Thomas Bergh
Director of Finance/CFO chez LINC AB
Fortune : 6 M $ au 31/03/2024
Profil
Thomas Bergh is currently a Director at nWise AB, Oncorena Holding AB, Nwise ägare AB, and Animal Probiotics Sweden AB.
He is also currently serving as an Investment Manager at MedCap AB (Private Equity) since 2016 and as the Chief Financial Officer at Linc AB since 2020.
Previously, he worked as a Director at Cardiolex Medical AB and Morgan Stanley AB.
From 2016 to 2020, he was an Investment Manager at MedCap AB.
Mr. Bergh holds a graduate degree and an MBA from Stockholm School of Economics.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LINC AB
1,73% | 24/10/2023 | 1 000 000 ( 1,73% ) | 6 M $ | 31/03/2024 |
Postes actifs de Thomas Bergh
| Sociétés | Poste | Début |
|---|---|---|
| LINC AB | Director of Finance/CFO | 01/01/2020 |
MedCap AB (Private Equity)
 MedCap AB (Private Equity) Investment ManagersFinance MedCap AB (ST: MCAP) is an industrial holding company established in 2001 and based in Stockholm. MedCap focuses on small and medium-sized firms active in the life sciences sector. | Private Equity Investor | 01/02/2016 |
nWise AB
 nWise AB Packaged SoftwareTechnology Services nWise AB is a leading provider of technology and knowledge that develops, operates, and supports advanced platform-based communications solutions. The private company is based in Solna, Sweden, and the CEO of the company is Niklas Cassel. The Swedish company's communication platform MMX delivers functional and accessible technology based on Total Conversation and Real-Time Text (RTT), revolutionizing DeafBlind Telecommunication with myMMX. nWise develops comprehensive, reliable, and easy-to-use technology that provides people who are Deaf, DeafBlind, and Hard of Hearing access to telecommunications through video, RTT, and voice. | Director/Board Member | - |
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Director/Board Member | - |
| Nwise ägare AB | Director/Board Member | - |
| Animal Probiotics Sweden AB | Director/Board Member | - |
Anciens postes connus de Thomas Bergh
| Sociétés | Poste | Fin |
|---|---|---|
| MEDCAP AB | Chief Investment Officer | 01/01/2020 |
Cardiolex Medical AB
 Cardiolex Medical AB Medical SpecialtiesHealth Technology Cardiolex Medical AB operates as a medical technology company that engages in the development and marketing of ECG devices and ECG management systems. Its products include EC Sense, EC View, EC Store, quickels, and accessories and spare parts. The firm's services include training, support and maintenance, and integration external systems. The company is headquartered in Solna, Sweden. | Director/Board Member | - |
Morgan Stanley AB
 Morgan Stanley AB Investment ManagersFinance Morgan Stanley AB provides investment banking services. The company is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | - |
Formation de Thomas Bergh
| Stockholm School of Economics | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MEDCAP AB | Health Technology |
| LINC AB | Finance |
| Entreprise privées | 7 |
|---|---|
Cardiolex Medical AB
Cardiolex Medical AB Medical SpecialtiesHealth Technology Cardiolex Medical AB operates as a medical technology company that engages in the development and marketing of ECG devices and ECG management systems. Its products include EC Sense, EC View, EC Store, quickels, and accessories and spare parts. The firm's services include training, support and maintenance, and integration external systems. The company is headquartered in Solna, Sweden. | Health Technology |
MedCap AB (Private Equity)
MedCap AB (Private Equity) Investment ManagersFinance MedCap AB (ST: MCAP) is an industrial holding company established in 2001 and based in Stockholm. MedCap focuses on small and medium-sized firms active in the life sciences sector. | Finance |
Morgan Stanley AB
Morgan Stanley AB Investment ManagersFinance Morgan Stanley AB provides investment banking services. The company is headquartered in Stockholm, Sweden. | Finance |
nWise AB
nWise AB Packaged SoftwareTechnology Services nWise AB is a leading provider of technology and knowledge that develops, operates, and supports advanced platform-based communications solutions. The private company is based in Solna, Sweden, and the CEO of the company is Niklas Cassel. The Swedish company's communication platform MMX delivers functional and accessible technology based on Total Conversation and Real-Time Text (RTT), revolutionizing DeafBlind Telecommunication with myMMX. nWise develops comprehensive, reliable, and easy-to-use technology that provides people who are Deaf, DeafBlind, and Hard of Hearing access to telecommunications through video, RTT, and voice. | Technology Services |
Oncorena Holding AB
Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
| Nwise ägare AB | |
| Animal Probiotics Sweden AB |
